1. No category

1
2
6
16
22
26
30
32
34
36
(
)
97
8
30
16
97
10
1
97
8
31
16
1
27
0970174994
3
26
97
8
31
16
1
2009
AUA
(1)
14
(AUA)
4
(1)
17
25
)~30
(
)
Chicago,
4
Illinois
25
(2)
(
2009
(
)
Pre-
AUA World Chinese-speaking
Urologist Society meeting
(2)
97
11
25
(
)
12
(3)
(
) Email
10-15
(4)
(3)
AUA
http://www.aua2009.org/
1
2
17
68
41/318
(The 17th Asian
13
9
(
)
Congress of Surgery & the 68th
Annual Meeting of Taiwan Surgical
57/187
Association)
30
6
2008
11
(
)
50/318
15
16
9
(
)
(
(
http://www.acs2009.org
(FDA)
(Surgical Mesh)
http
//www.fda.gov/cdrh
48/136
/safety/102008-surgicalmesh.html
35
2
(
http
(
)
/ / a d r.
02-2396-0100)
doh.gov.tw
169
1.(E)2.(E)3.(B)4.(E)5.(A)
97
9-10
45
7
3
3
20/44
)
(
49/136
36
5
(
)
5
4
97
10
0970214592
11
10
25
22
753~774
97
22
3
3
71.8
67.2
70.45%
63/187
34
5
)
(
98
97
7
16
20%
0970201744
10%
98
72
66
97
1
97
98
11 10
8
16
98
0970215637
1
2
2
5
1
3
1
1
1
3
1
1
3
4
5
6
7
8
9
10
5
6
11
41
1
1
42
1
1
43
1
2
3
44
1
2
2
3
45
1
1
16
1
1
46
1
1
17
1
2
47
1
2
18
1
1
48
1
1
19
1
1
49
1
1
20
1
1
50
1
1
21
1
1
51
1
2
22
1
1
52
1
1
23
1
1
53
1
2
24
1
1
54
1
1
25
1
1
55
1
1
26
1
1
56
1
2
27
1
2
57
1
1
28
1
1
58
1
2
29
1
1
59
1
1
30
1
1
60
1
1
31
1
1
61
1
1
32
1
1
62
1
1
33
1
7
63
1
3
34
1
1
64
1
2
35
1
2
65
1
1
36
1
1
66
1
1
37
1
1
67
1
1
38
2
3
66
97
39
1
1
40
1
1
2
4
13
1
1
14
2
15
12
7
98
(98
7
1
99
6
30
)
8
1
7
3
( 98
55
3 (
97
7
1
7
1
101
I
)
5
96 7
)
97
100 6 30
3
6 30
98
1
99
6
96
1.
30
96
97
11 22
10:00-14:00
11C
98
2.
97
11
22
10
(TEP)
3.
2
97
(
11 20
(02)2729-0864
1,P10)
4.
(02)2729-0819
3
5.
97
11
29
12
2
WPCCID
Kurt Naber
Tetsuro Matsumoto
)
Krieger
(
Vu le Chuyen
(
)
Yong-hyun Cho
)
12
(
11C
3
)
6.
Joichi Kumazawa (
(
)
John
(0968-663-369)
(02)2729-0819
Mr. GUNTER HAESAERTS and Dr. Henri Botto
Bill Wong
17
6
7
39
E-mail
PS.
2.3,P.11~14
/
9
10
2
Pre-Congress Meeting of the 5th Asian Association of UTI and STD
(AAUS)
Date: Nov. 29, 2008
Venue: Taipei International Conference Center (TICC)
Hosted by Taiwan Urological Association and AAUS.
Chaired by Stephen S. Yang
3. Comments from Europe
10 min
4. Moderated discussion
10 min
Kurt Naber (German)
1150-1220 Special Communication I: Cranberry for preventing recurrent UTI
Moderators: Shih-Ping Liu
(Taiwan) and Bill Wong (Hongkong)
Speakers: Mr. Gunter Haesaerts and Dr. Henri Botto (France)
25 minutes lecture and 5 minutes discussion.
0830-0840
Opening
President of AAUS: Tetsuro Matsumoto
1220-1350
Lunch
1350-1510
Symposium III: Recent Advances in Sexual Transmitted Disease
Chairman of 5th AAUS Meeting Stephen S. Yang
0840-0920
Moderators; Hiromi Kumon (Japan), Ching-Pao Chang
Keynote Lecture: by President Tetsuro Matsumoto
Moderator: Stephen S. Yang
Each lecture: 18 minutes and Discussion: 2 minutes.
(Taiwan)
New frontier in the research of UTI
30min
Discussion: 10 min.
0920-1030
(Taiwan)
1) HIV infection, an update for urologists
Seung-Ju Lee (Korea)
2) Gonococcal and chlamydial urethritis
Yueng-Wei Wang
3) Genital herpes
Wei-Pao Chen
(Taiwan)
4) Update Diagnosis and Treatment for Genital Warts. Jesun Lin
Symposium I: Antimicrobial prophylaxis for urological surgery
(Taiwan)
(Taiwan)
Moderator: Kurt Naber and Sang Don Lee (Korea)
1510-1530
1. Introduction: Background for the guidelines, standards and best practices
3 minutes
Coffee break
John Krieger (USA)
2. Antimicrobial prophylaxis for urological surgery
20min
1530-1630 Symposium IV: Update on Managing Genitourinary Tuberculosis
Taiwan experience
Yao-Shen Chen
(Taiwan)
Moderators: Yong Hyun Cho (Korea) and Saint Chen
3. Japanese guideline
20 min
Soichi Arakawa (Japan)
Each lecture 18 minutes and discussion 2 minutes.
4. Best practice for prophylaxis
10min
John Krieger (USA)
1. Managing TB in the era of high drug resistance. Chun-Hsing Liao
5. Taiwanese guideline
10 min Yii-Her Chou
6. Moderated discussion
10 min
(Taiwan)
(Taiwan)
(Taiwan)
2. Genitourinary tuberculosis (GUTB): diagnosis and treatment at binh dan hospital
Vu le Chuyen (Vietnam)
3. Urological management of genital tract TB (epidymidis and prostate)
Ying-Huei Lee
1030-1050
Coffee break: 20 min
1050-1150
Syposium II: Catheter Associated UTI: CAUTI
Moderators: Chien Bang-Ping
1630-1700 Special Communication II: The role of urological intervention in complicated UTI.
(Taiwan) and Vu Le Chuyen (Vietnam).
Moderator:
Shing-Hwa Lu
Shinya Uehara (Japan)
(Taiwan)
1. European and Asian guideline.
30 min
Shingo Yamamoto (Japan)
Speaker:
2. Comments from US
10 min
John Kriger (USA)
25 minutes lecture and 5 minutes discussion.
1700-1705: Closing remarks.
11
(Taiwan)
Stephen S. Yang
(Taiwan)
12
Scientific Program in the 11th WPCCID and 5th AAUS (UTI related
topics):
November 30-December 3, 2008
Sunday November 30, 2008: 1420-1500
1300-1400, December 1, 2008. (Monday)
Business meeting of AAUS. Tetsuro Matsumoto.
Oral Session 10
Speaker: John Krieger (USA)
Moderator: Seung-Ju Lee (Korea) and Hsieh Cheng-Hsing
(Taiwan)
Urological Infections and Sexually-Transmitted Diseases
30 minutes lecture plus 10 minutes discussion.
Co-chairs:
Sunday, November 30, 2008: 1530-1700
OS10-01 Infectious Complications and Causative Microorganisms after
Symposium U1: Management of Complicated UTI
Transrectal Ultrasound-guided Prostate Needle Biopsy
Moderators; Joichi Kumazawa (Japan), Chul Sung Kim (Korea)
Jae Young Park (South Korea)
Each lecture: 20 minutes and Discussion: 10 minutes.
1.The risk factors and management of recurrent UTI
OS10-02
Bong Suk Shim (Korea)
renal abscess, renocolonic fistula, etc).
Cheng-Hsing Hsieh (Taiwan)
Mitsuru Yasuda (Japan)
OS10-03 The Role of Zinc Amino Acid Chelate in Bacterial Prostatitis
3. Complex prostatic infection: (Prostatic abscess, acute bacterial prostatitis, chronic bacterial
prostatitis, etc.)
Animal Model
In Rae Cho (Korea)
4. Management of urosepsis.
Hsieh Cheng-Hsing
Hong Seok Park (South Korea)Hong Seok Park (South Korea)
(Taiwan)
OS10-04 Antibiotic Susceptibility Patterns of Urinary Isolates in a Tertiary-
5. Discussion
teaching Hospital in Malaysia: A 2 Year Review
Nabilah Ismail (Malaysia)
Monday, December 1, 2008: 8:30-9:10
OS10-05 Antimicrobial Susceptibility of Various Antibiotics against Neisseria
Keynote Lecture: Optimal management of urinary tract infections - EAU guidelines updated. Kurt
gonorrhoeae Isolates in Japan
Naber, President of International Society of Chemotherapy (Germany)
Tomoko Kobayashi (Japan)
Moderator: Joichi Kumazawa (Japan)
OS10-06 Comparison of Susceptibilities to Neisseria gonorrhoeae Determined
Using GC Agar and Chocolate Agar
Monday, December 1, 2008: 1030-1200,
Chun-Hsing Liao (Taiwan)
Symposium U2: Voiding dysfunction and UTI
Moderators: Tetsuro Matsumoto (Japan) & Chen Wen-Chi
(Taiwan)
20 min Bill-Wong
(Hong-Kong)
2. Female incontinence and UTI or Women and UTI
20 min Sun Ju Lee (Korea)
3. Neurogenic bladder and UTI
20 min Satoshi Takahashi (Japan)
4. Pediatric voiding dysfunction and UTI
20 min Stephen Yang
13
Urosepsis Syndrome in Adults With Complicated Urinary Tract
Infections
2. Complex renal infection: (Xanthogranulomatous pyelonephritis, Emphysematous pyelonephritis,
1. BPH and UTI
10min .
Tuesday, December 2, 2008 15:30-17:00
Plenary lecture (8): Circumcision and Prevention of HIV
Moderators: Han-Sun Chiang
5. Moderated discussion
1
WPCCID
2
10
12
3
10
14
1995
(melamine)
Medline
-
1,3,5-Triazine-2,4,6-triamine
1983
15
Liebig
16
(
350
)
50%
3000
1000
ppm)
(3000
(
300
)
60
18
6
Okumura
Kjeldahl method
F344
thymine
3.0
1.0%
melamine
thymine
3.0, 1.0
36
1.0%
40
melamine
(79%)
4
0.3%
1/20
3.0% thymine, 3.0%
(63%)
1/20 (5%)
(70%)
3.0% melamine
(5%)
3.0%
3.0%
melamine
1.0% melamine
36
1/19(5%)
10/10 (100%)
7/10
3/19 (16%)
3.0% thymine
3
15/19
9/20 (45%) 12/19
9/10 (90%)
5
thymine
F344
3.0%
F344
B6C3F1
13
750
(
18,000 ppm
2250 or 4500 ppm
)
103
(
)
6000
18,000 ppm
4500
9000 ppm
13
4500 ppm (
(0/45)
)
(8/49)
(p<0.016)
(2250 ppm)
Ogasawara
3
F344/DuCrj
1%
10
5%
10%
36
13
3%
90 %
0%
42%
55%
15%
1%
21%
0%
(
17
10%
61.1-81.2%)
18
3. Melnick RL, Boorman GA, Haseman JK, Montali RJ, Huff J. Urolithiasis and bladder
carcinogenicity of melamine in rodents. Toxicol Appl Pharmacol 1984;72:292-303.
4. Heck HD, Tyl RW. The induction of bladder stones by terephthalic acid, dimethyl terephthalate,
and melamine (2,4,6-triamino-s-triazine) and its relevance to risk assessment. Regul Toxicol
Pharmacol 1985;5:294-313.
5. UNEP publications: Melamine, CAS No.: 108-78-1.
6. Lee YH, Huang WC, Tsai JY, Lu CM, Chen WC, Lee MH, Hsu HS, Huang JK, Chang LS.
Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int
2002;68:172-7.
180(1.8%)
2002
9.6%
1593
1. Ogasawara H, Imaida K, Ishiwata H, Toyoda K, Kawanishi T, Uneyama C, Hayashi S, Takahashi
M, Hayashi Y: Urinary bladder carcinogenesis induced by melamine in F344 male rats:
correlation between carcinogenicity and urolith formation. Carcinogenesis 1995;16:2773-7.
2. Okumura M, Hasegawa R, Shirai T, Ito M, Yamada S, Fukushima S: Relationship between
calculus formation and carcinogenesis in the urinary bladder of rats administered the nongenotoxic agents thymine or melamine. Carcinogenesis 1992;13:1043-5.
19
11051
432
6
1
12
(
)
100
80
31
3
1.
4.
(A)
(A)
(B)
(C)
(D)
350
C
(B)
(C)
2.
(D)
(A)
(B)
(C)
(D)
5.
(A)
3.
(B)
(A)
(C)
(B)
(D)
(C)
(
(promoter)
(D)
Mayo stand
)
(inhibitor loss)
30~45
(PACS
)
170
1.(
)
2.(
)
3.(
)
4.(
)
5.(
)
(
11
(
(
15
22
)
(
)
(
)
)
20
(
)
)
22
(square knot)
(sliding knot)
13
30
97
09700003951
97
1
1
16
18
15
6
1593
1
16
20
30
5
11051
432
09400016851
6
1
28
09500005861
18
23
26
)
24
Dr. Christopher Chapple 97
12
(
)
100
31
80
1.
4. 97
(A)
(B)
(C)
(D)
(E)
1
16
09700003951
97
1
18
(A)
(B)
(C)
(D)
2.
(E)
(A)
(B)
(C)
(D)
(E)
5.
3.
13
(A)10
(A)
(B)
(C)
(D)
(B)20
(C)30
(D)40
(E)50
(E)
170
1.(
)
(
(
2.(
)
3.(
)
4.(
)
5.(
)
)
)
(
)
26
27
28
97/11/7-9
The 4th International Congress on the History of Urology
Linthicum, Maryland, USA
Web address: http://www.urologichistory.museum/congress/
97/11/20-22
SIU World Uro-Oncology Update
Santiago, Chile
Web address: http://www.siucongress.org/
E-mail address: [email protected]
97/11/21-23
17th Malaysian Urological Conference
Kuala Lumpur, Malaysia
Web address: http://www.muacme.org
E-mail address:[email protected]
97/11/29-12/3
5th 2008 AAUS (Asian Association of UTI and STD)
Taipei, Taiwan
E-mail address:[email protected]
97/11/30-12/3
26th World Congress of Endourology
Shanghai, China
E-mail address:[email protected]
98/2/7-11
European Urology Forum 2009
Davos, Switzerland
E-mail address: http://www.uroweb.org/
E-mail address: [email protected]
98/3/7-10
9th International Congress of Andrology (ICA)
Barcelona, Spain
Web address: http://www.eaustockholm2009.org/home/
29
30
98/3/17-21
Annual European Association of Urology (EAU) Congress
Stockholm, Sweden
Web address: http://www.eaustockholm2009.org/home/
98/4/25-30
2009 AUA Annual Meeting
Chicago, Illinois
Web address: http://www.aua2009.org/
98/7/10-13
Web address: http://www.icsm2009.org/
E-mail address:[email protected]
11/22( )
9:00
1F
20th Video Urology World Congress in conjunction with 18th Malaysian
Kuala Lumpur, Malaysia
E-mail address: [email protected]
International Continence Society (ICS) 39th Annual Meeting
11/23( )
8:30
|
16:10
11/29( )
8:30
|
12/3( )
14:00
San Francisco, USA
Web address:http://www.kenes.com/continence-meeting/
E-mail address:[email protected]
(
17:00
Urological Conference
98/9/30-10/4
(
)
3rd International Consultation on Sexual Medicine
Paris, France
98/7/24-26
(
2008
6
102
TCS Annual
Meeting
(11th
WPCCID)
5th Asian UTI STD
Forum( AAUS 2008)
(02)86719336
)
(02)25044338
10
(
3
2
)
2
Genetic Diagnosis of Male
(05)2648000
(
138 )
Infertility
#18
#5240
TAA Symposium :
3
(02)87894295
3
0970332287
701
(
707
Endoscopic Surgery in
Urology
31
5
10
1
16:30
8:30
)
(
12/13( )
13:30
12/19( )
7:30
(02)87894295
(
1
8:30
11:55
5
)
11
12/2( )
7:30
12/6( )
9:00
)
(
)
(
)
17F
118
3F
139
1.5
)
(04)24632000
#3660
32
(
(
)
12/20( )
13:30
6F
(
57
16:00
12/20( )
14:00
15:00
)
3
(06)2748316
1F
(
3
6 )
17:30
12/27( )
13:30
)
(04)7256166
#81293
B4
(
3
95
)
(02)28332211
#2080
(
(
)
(
)
101
11/19( )
8:00
|
9:00
11/20( )
9:00
|
10:00
(
1.2
1
)
6F
(
125 )
#65023
1.2
(
1.2
100
)
4F
(
(
_Effective use of words
482
)
11/21( )
12:00
|
14:00
2F
2.4
)
(
478
11/22( )
7:30
|
8:30
1.8
)
(06)2200055
#5413
1F
(
2
2.
.
)
1.2
B1
(
3.
4.
325 )
(03)3384889
#2141
(07)8036783#34
97(
)
(049)2231150
#2262
1.
11/22( )
8:40
|
17:00
(02)23123456
B1
11/20( )
15:00
|
16:00
11/20( )
17:00
|
19:00
)
8.4
(04)22052121
#4332
(04)22522760#2
2,800
4(
/
,
.
.
.
,
http://www.edce
du.com
5.
(04)22590289)
11/24( )
12:15
|
13:30
33
6F
97
EBM
(
1.5
100
)
(07)3121101
#5380
34
(
(
)
11/24( )
13:00
|
14:30
9F
(
6
11/24( )
16:00
|
18:00
2.4
289
)
(
(037)357125#43
05(
,
)
12/16( )
9:00
|
10:00
(02)66289779
12/17( )
8:00
|
9:00
#7305
(
)
13F(
(
74
2.4
)
(
1.2
386
)
4F
(
(
_Introduction
482
)
12/1( )
16:00
|
17:00
)
(02)23510756#1
06(
)
(07)3422121
2F
(
#2098
2.4
(07)8036783
#3497(
)
1.2
(02)66289779
#7305
4
138
)
1.2
6F
(
123
1.2
)
289
)
rational use of
antimicrobial agents
(
138 )
1.2
(06)2353535#53
#5383
(07)7317123
6F
97
(07)3121101
(
EBM
100
1.5
)
#5380
684-307
2.
117 (
4
(06)2353535
0935-
Infection control and
2F
(02)66289779#
7305
#8800
1.
13F(
)
-
12/18( )
7:30
|
8:30
12/31( )
12:15
|
13:30
1.2
289 )
6F
11/27( )
14:00
|
15:00
12/2( )
8:00
|
9:00
)
13F(
11/25( )
13:00
|
15:00
11/27( )
17:00
|
19:00
1.8
)
3.
43303)
97
11
8
97
11
(
)
8:00
9
(
)
17:00
83
(02)2323141618
12/10( )
8:00
|
9:00
12/10( )
12:30
|
14:30
35
14F
4.
(
( )
21
)
1.2
(02)89667000
"
(
")
579
)
2.4
(05)5323911
)
11:30
16
(
)
17:30
(02)23756518
5.
6F
Status of Morality(
(
12
#2814
The Epistemological
15
(03)3179599#7270
#2323
36
(0227290864)
100
1,500
14013139
TUA Edu 002
TUA Edu 003
(
)
TUA Edu 004
TUA Edu 005
TUA Edu 006
TUA Edu 007
TUA Edu 008
TUA Edu 009
TUA Edu 010
TUA Edu 011
TUA Edu 012
TUA Edu 013
(BCG,IMMUCYST)
TUA Edu 014
TUA Edu 015
37
NT$400
169